Podcast: Sutro Biopharma and Cell-Free Protein Expression Systems - - BioPharm International

ADVERTISEMENT

Podcast: Sutro Biopharma and Cell-Free Protein Expression Systems


blog comments powered by Disqus


In this first of three podcast interviews, Dr. Hallam, chief scientific officer at Sutro Biopharma, introduces a non-traditional approach for expressing therapeutic proteins and peptides. More specifically, Sutro has developed a proprietary technology for manufacturing proteins in a cell-free system. The system uses a cell extract that contains the necessary machinery for producing protein without the need to maintain cell viability. Essentially, the bioreactor is the cell membrane for a giant cytosolic preparation. Dr. Hallam talks about the advantages of the system and even speculates as to future applications, for example, in a biodefense scenario. Posted Nov. 2011.

Related article on industrializing design, development, and manufacturing of therapeutic proteins

ADVERTISEMENT

ADVERTISEMENT

Despite AbbVie Snub, Shire Says it Will Double Sales by 2020
October 24, 2014
Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Author Guidelines

Click here